"Given Imaging is proud of its role as a leader in developing innovative products for GI diagnostics." Homi Shamir, CEO, Given Imaging

Given Imaging Ltd. was established in 1998 in Yoqneam, Israel, when a former missile engineer combined his knowledge with that of a medical doctor, in order to create a revolutionary diagnostic tool. That tool,the PillCam, is the first ingestible non-invasive disposable camera the size of a capsule that diagnosis gastrointestinal track diseases.  2008 An addition to the Given Imaging portfolio, the Bravo pH Monitoring System, is a gold standard method for pH monitoring of gastric reflux.  Bravo is the only wireless (catheter-free) ambulatory pH test to help clinicians manage gastro esophageal reflux disease.

Highlights

• In 2001, only three years after its founding, Given Imaging made worldwide  headlines when it introduced this revolutionary FDA approved PillCam™ Capsule Endoscopy to the world. The PillCam™ replaces painful and invasive endoscopy and enterscopy diagnostic procedures through the simple yet innovative technique of swallowing a capsule capable of transmitting fifty thousand real-time images to a receiver belt worn by the patient and which can then be reviewed by a physician.

• The PillCam™ helps diagnose Crohn's Disease, celiac disease, malabsorption disorders and benign and malignant tumors of the small intestine. It can also detect vascular disorders, medication-related small bowel injuries, and a range of pediatric small bowel disorders often remaining undiagnosed using other procedures.

• 2003: The PillCam™ was approved for use in pediatric patients

• 2004-PillCam ESO which provides a patient-friendly alternative to esophageal endoscopy and the associated sedation and discomfort was approved.

• 2006-The PillCam COLON video capsule for visualization of the colon was cleared for marketing in the European Union, and multi-center clinical trials are underway in Europe and the U.S.

• 2007-Given Imaging Ltd. received approval from the European Commission of the Sixth EU Framework Program of Research and Technological Development to help develop patient-friendly, highly sensitive early cancer detection technology as part of the NEMO project.

• Currently, the PillCam™ is marketed in over 60 countries, including the US, Australia, New Zealand, Canada, China, South Korea and Latin America and has been adopted by major health insurers.

• 2008-Veteran's Administration National Acquisition Center granted Given Imaging a new 5-year Federal Supply Schedule (FSS) contract with revenue anticipated at $7.5 million for the contract period.

• A 2008 portfolio addition, the Bravo pH Monitoring System, is a gold standard method for pH monitoring of gastric reflux.  Bravo is the only wireless (catheter-free) ambulatory pH test to help clinicians manage gastro esophageal reflux disease.

• In April, 2010, Given Imaging acquired privately-held Sierra Scientific Instruments, the world leader in high-resolution manometry products and acid reflux monitoring solutions, including pH and impedance monitoring. 

Awards

• The Wall Street Journal awarded Given Imaging the 2004 Technology Innovation award for the PillCam™ video capsule. The company received first place in the medical category and the silver medal overall.

• 2007 - Given Imaging selected as 2007 World Economic Forum Technology Pioneer

• 2010 -  The Eagle Star "Company of the Year" Award by the American-Israel Chamber of Commerce, Southeast Region

Returns

• Given Imaging was first listed on the NASDAQ in 2001, raising $60 million at $12 per share. After only two quarters, Given Imaging had net sales of $4.73 million.

• The company continues to be successful, having posted profits of $181 million in 2011.